Healthcare Reform, Public Perception Mean Greater Scrutiny of Pharma Meetings

The uncertain future of the country’s healthcare system has direct implications for biopharmaceutical and medical device companies, and in turn will affect the way these companies approach medical meetings and healthcare provider education, said Kim Slocum during a keynote address at the Sixth Annual Pharmaceutical Meeting Management Forum. Organized by Medical Meetings and the Center for Business Intelligence, the forum was held March 14–16 in Philadelphia.